Welcome to the investors section of Adocia
Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.
Latest Press Releases
2018/07/25Half year report on Adocia’s liquidity agreement with Kepler Capital Markets
2018/07/18Adocia Presents First Half 2018 Financial Results